125 related articles for article (PubMed ID: 23553334)
21. Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells.
Arayataweegool A; Srisuttee R; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Kitkumthorn N; Mutirangura A
Oral Dis; 2019 Jan; 25(1):64-72. PubMed ID: 30047194
[TBL] [Abstract][Full Text] [Related]
22. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma.
Bongers V; Braakhuis BJ; Snow GB
Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):479-82. PubMed ID: 8582085
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
24. PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma.
Hsu CM; Lin PM; Lai CC; Lin HC; Lin SF; Yang MY
Head Neck; 2014 Jul; 36(7):1018-26. PubMed ID: 23784787
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.
Wollenberg B; Jan N; Sautier W; Hofmann K; Schmitt UM; Stieber P
Tumour Biol; 1997; 18(2):88-94. PubMed ID: 9222306
[TBL] [Abstract][Full Text] [Related]
26. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Rampazzo E; Polesel J; Giunco S; Menegaldo A; Mantovani M; Stellin M; Bandolin L; Spinato G; Del Mistro A; Borsetto D; Fussey J; Tirelli G; Da Mosto MC; De Rossi A
Sci Rep; 2019 Nov; 9(1):17572. PubMed ID: 31772219
[TBL] [Abstract][Full Text] [Related]
27. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
29. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma.
Lu CT; Hsu CM; Lin PM; Lai CC; Lin HC; Yang CH; Hsiao HH; Liu YC; Lin HY; Lin SF; Yang MY
Anticancer Res; 2014 Dec; 34(12):7137-43. PubMed ID: 25503141
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
[TBL] [Abstract][Full Text] [Related]
31. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
[TBL] [Abstract][Full Text] [Related]
33. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
34. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
[TBL] [Abstract][Full Text] [Related]
35. Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Wang WL; Chang WL; Yeh YC; Lee CT; Chang CY; Lin JT; Sheu BS
Mol Carcinog; 2013 Jun; 52(6):438-45. PubMed ID: 22241750
[TBL] [Abstract][Full Text] [Related]
36. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.
Beschel LM; Leu M; Reichardt SD; Rave-Fränk M; Schirmer MA; Stadelmann C; Canis M; Wolff HA; Reichardt HM
Oncotarget; 2016 Oct; 7(40):65902-65915. PubMed ID: 27589568
[TBL] [Abstract][Full Text] [Related]
37. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
[TBL] [Abstract][Full Text] [Related]
38. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.
Choudhury B; Srivastava S; Choudhury HH; Purkayastha A; DuttaGupta S; Ghosh SK
Tumour Biol; 2014 Jul; 35(7):6739-48. PubMed ID: 24715304
[TBL] [Abstract][Full Text] [Related]
39. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
40. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K;
Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
